| Recruiting | A Study of MIL116 in Healthy Participants and Patients With IgA Nephropathy. Immunoglobulin A Nephropathy | Phase 1 / Phase 2 | 2026-02-05 |
| Not Yet Recruiting | A Phase 3 Clinical Study of MIL62 in Systemic Lupus Erythematosus Systemic Lupus Erythematosus | Phase 3 | 2026-02-01 |
| Recruiting | A Study of MBS314 in Participants With Relapsed/Refractory Multiple Myeloma. Relapsed or Refractory Multiple Myeloma | Phase 1 / Phase 2 | 2024-02-22 |
| Recruiting | A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy Study of MBS303 in B-Cell NHL Non-Hodgkin's Lymphoma | Phase 1 / Phase 2 | 2023-06-28 |
| Active Not Recruiting | A Phase Ⅲ Clinical Study of MIL62 in Primary Membranous Nephropathy Primary Membranous Nephropathy | Phase 3 | 2023-06-02 |
| Active Not Recruiting | A Phase 2 Clinical Study of MIL62 in Systemic Lupus Erythematosus Systemic Lupus Erythematosus | Phase 2 | 2023-05-26 |
| Active Not Recruiting | A Study of MIL62 in Patients With Neuromyelitis Optica Spectrum Disorder (NMOSD) Neuromyelitis Optica Spectrum Disorder | Phase 3 | 2022-08-18 |
| Completed | A Phase Ib/ Ⅱ Clinical Study of MIL62 in Primary Membranous Nephropathy Primary Membranous Nephropathy | Phase 1 / Phase 2 | 2022-02-24 |
| Recruiting | Treatment of Advanced and Metastatic Solid Tumors With MIL97 Advanced or Metastatic Solid Tumor | Phase 1 | 2022-01-18 |
| Active Not Recruiting | Evaluation of the Tolerance, Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of MIL62 Injection for T Lupus Nephritis | Phase 1 / Phase 2 | 2021-11-26 |
| Recruiting | MIL62 Combined With Lenalidomide Versus Lenalidomide for Patients With Rituximab Refractory Follicular Lymphom Follicular Lymphoma and Marginal Zone Lymphoma | Phase 3 | 2021-06-02 |
| Unknown | A Clinical Study of MIL93 in Solid Tumors. Advanced Malignancies | Phase 1 | 2021-04-21 |
| Recruiting | A Clinical Study of MIL95 in Advanced Malignancies. Advanced Malignancies | Phase 1 | 2021-01-04 |
| Recruiting | MIL62 Plus Lenalidomide for Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (FL and MZL) Follicular Lymphoma and Marginal Zone Lymphoma | Phase 1 / Phase 2 | 2019-11-28 |
| Recruiting | Phase I Clinical Study of MBS301 in Treatment of HER2 Positive Recurrent or Metastatic Malignant Solid Tumor HER2-positive Recurrent or Metastatic Malignant Solid Tumor | Phase 1 | 2019-04-11 |
| Completed | mil60 Versus Bevacizumab in Patients With Treatment-naïve Non-squamous Non-small Cell Lung Cancer Non-small Cell Lung Cancer | Phase 3 | 2017-08-15 |
| Completed | A Study of MIL62 in Treatment of CD20 Positive B-cell Lymphomas CD20-positive B Cell Non-Hodgkin Lymphoma | Phase 1 | 2017-02-10 |